Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Irini Grapsa"'
Autor:
Ioannis Papaconstantinou, Anneza I. Yiallourou, Nicolaos Dafnios, Irini Grapsa, George Polymeneas, Dionysios Voros
Publikováno v:
Case Reports in Medicine, Vol 2011 (2011)
A 67-year-old male patient with diabetes mellitus and nephritic syndrome under cortisone treatment was admitted to our hospital with fever and severe perianal pain. Upon physical examination, a perianal abscess was identified. Furthermore, the scrotu
Externí odkaz:
https://doaj.org/article/17fb4195b0e0477fb207bd10128ebc45
Autor:
Efstathios Kastritis, Athanasios Anagnostopoulos, Maria Roussou, Dimitra Gika, Charis Matsouka, Despina Barmparousi, Irini Grapsa, Erasmia Psimenou, Aristotle Bamias, Meletios Athanasios Dimopoulos
Publikováno v:
Haematologica, Vol 92, Iss 4 (2007)
The impact of high dose dexamethasone containing regimens with or without the novel agents thalidomide and bortezomib on the reversal of renal failure (RF) was evaluated in 41 consecutive newly diagnosed patients with multiple myeloma (MM) treated in
Externí odkaz:
https://doaj.org/article/191a7c3c12fe49bf8c47a8503d37a8ad
Autor:
Athanasios Anagnostopoulos, Dimitra Gika, Aristotle Bamias, Erasmia Psimenou, Despina Barmparousi, Charis Matsouka, Maria Roussou, Meletios A. Dimopoulos, Irini Grapsa, Efstathios Kastritis
Publikováno v:
Haematologica. 92:546-549
The impact of high dose dexamethasone containing regimens with or without the novel agents thalidomide and bortezomib on the reversal of renal failure (RF) was evaluated in 41 consecutive newly diagnosed patients with multiple myeloma (MM) treated in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::755d3da3533b45e73e72e2d08c5cb6c2
https://doi.org/10.3324/haematol.10759
https://doi.org/10.3324/haematol.10759
Autor:
Erasmia Psimenou, Efstathios Kastritis, Maria Roussou, Maria Gavriatopoulou, Dimitrios Christoulas, Meletios A. Dimopoulos, Magdalini Migkou, Irini Grapsa, Dimitra Gika, Evangelos Terpos
Publikováno v:
Leukemia Research. 34:1395-1397
The purpose of this analysis was to assess the effect of novel agent-based regimens on the improvement of renal impairment (RI) in newly diagnosed patients with multiple myeloma. Ninety-six consecutive patients with RI received conventional chemother
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35afa31535b1d8c8d55b15641ba7b4c1
https://doi.org/10.1016/j.leukres.2010.04.024
https://doi.org/10.1016/j.leukres.2010.04.024
Autor:
Irini Grapsa, George Polymeneas, Ioannis Papaconstantinou, Dionysios Voros, N. Dafnios, Anneza I. Yiallourou
Publikováno v:
Case Reports in Medicine
Case Reports in Medicine, Vol 2011 (2011)
Case Reports in Medicine, Vol 2011 (2011)
A 67-year-old male patient with diabetes mellitus and nephritic syndrome under cortisone treatment was admitted to our hospital with fever and severe perianal pain. Upon physical examination, a perianal abscess was identified. Furthermore, the scrotu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01c9d64f387fc8b8ff688853396a55bf
http://europepmc.org/articles/PMC3034918
http://europepmc.org/articles/PMC3034918
Autor:
Maria Roussou, Despoina Mparmparoussi, Charis Matsouka, Maria Gavriatopoulou, Efstathios Kastritis, Evangelos Terpos, Dimitrios Christoulas, Eleni Efstathiou, Irini Grapsa, Erasmia Psimenou, Magdalini Migkou, Meletios A. Dimopoulos
Publikováno v:
European journal of haematology. 85(1)
Objectives: Lenalidomide and dexamethasone (LenDex) is an active regimen for relapsed/refractory multiple myeloma (MM). However, there is limited data for the effect of LenDex on renal impairment (RI) and on renal reversibility. Patients & Methods: F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6975394dd66e0aedab9861b1aafeac7c
https://pubmed.ncbi.nlm.nih.gov/20192988
https://pubmed.ncbi.nlm.nih.gov/20192988
Autor:
Magdalini Migkou, Meletios A. Dimopoulos, Irini Grapsa, Despina Barmparousi, Maria Roussou, Evangelos Terpos, Charis Matsouka, Efstathios Kastritis, Erasmia Psimenou
Publikováno v:
Leukemialymphoma. 49(5)
Renal failure is a common feature of multiple myeloma and a major management problem. However there is limited data regarding the reversibility of renal failure, the kinetics of serum creatinine and the safety of novel agents such as bortezomib when
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8de3498ede565abd501b458e0ed0e27
https://pubmed.ncbi.nlm.nih.gov/18452070
https://pubmed.ncbi.nlm.nih.gov/18452070
Autor:
Maria Roussou, Marina Iakovaki, Irini Grapsa, Despina Mparmparoussi, Meletios A. Dimopoulos, Maria Gkotzamanidou, Magdalini Migkou, Efstathios Kastritis, Erasmia Psimenou, Eleni Efstathiou, Maria Gavriatopoulou, Dimitrios Christoulas, Charis Matsouka, Evangelos Terpos
Publikováno v:
Blood. 114:3871-3871
Abstract 3871 Poster Board III-807 Lenalidomide and dexamethasone (RD) is an active regimen for the management of relapsed and/or refractory multiple myeloma (MM). Over the last 2 years consecutive patients with pre-existing peripheral neuropathy gra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01be53b025206b406e2eafc04b6ab408
https://doi.org/10.1182/blood.v114.22.3871.3871
https://doi.org/10.1182/blood.v114.22.3871.3871
Autor:
Magdalini Migkou, Charis Matsouka, Maria Roussou, Despina Mparmparoussi, Dimitrios Christoulas, Erasmia Psimenou, Efstathios Kastritis, Meletios A. Dimopoulos, Maria Gavriatopoulou, Evangelos Terpos, Irini Grapsa, Dimitra Gika
Publikováno v:
Blood. 114:955-955
Abstract 955 Renal impairment (RI) is a common complication of multiple myeloma (MM) and is associated with increased mortality. High dose dexamethasone-based regimens have been extensively used for the initial management of patients with MM presenti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe2f2b7f0d3655396aa020627baefcbc
https://doi.org/10.1182/blood.v114.22.955.955
https://doi.org/10.1182/blood.v114.22.955.955
Autor:
Despina Barmparousi, Erasmia Psimenou, Charis Matsouka, Efstathios Kastritis, Maria Roussou, Meletios A. Dimopoulos, Irini Grapsa, Flora Zagouri, Dimitrios Christoulas, Evangelos Terpos, Magdalini Migkou, Maria Gavriatopoulou
Publikováno v:
Blood. 112:1725-1725
Renal impairment (RI) is a frequent complication of multiple myeloma (MM) and a major management problem. Previous studies have shown that bortezomib is active and well tolerated in MM patients with RI and can be associated with improvement of renal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96326e039ceb0f5177e0f2c294b88667
https://doi.org/10.1182/blood.v112.11.1725.1725
https://doi.org/10.1182/blood.v112.11.1725.1725